Copenhagen University is now offering a Master on Headache Disorders. It´s a continuing professional development programme for healthcare professionals. The programme of the Master on Headache Disorders requires a minimum of 6 individual visits to Copenhagen, Denmark over a two-year period: Modules 1 to 4 are organized with an e-learning self-study period followed by one week […]
Master on Headache Disorders Read More »
INDIANAPOLIS, Sept. 21, 2018 Lilly Receives Positive CHMP Opinion for EmgalityTM (galcanezumab) for the Prophylaxis of Migraine in Adults Eli Lilly and Company announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Emgality TM (galcanezumab) for the prophylaxis of migraine in adults who have at least
Lilly Receives Positive CHMP Opinion for Emgality Read More »
Active Citizenship Network launch the second edition of the bi-annual research-project at the European level “European Civic Prize on Chronic Pain – Collection of good practices” with the aim to continue to give evidence on existing good practices in several European countries in terms of the struggle against pain. Aims of the project Giving continuity
European Civic Prize on Chronic Pain Read More »
How can this even be a trend!!!!???? Headache Pose? Migraine Pose? What is this supposed to mean? Migraine is not a pose but a neurological disorder involving nerve pathways and brain chemicals, which leaves completely disabled anyone who suffers an attack for an uncertain period of time. It´s very sad and outrageous that such an important
The #MigrainePose “Trend” Read More »
EMHA Executive Director Mrs. Elena Ruiz de la Torre flew the past month of August to Zurich in order to attend the first EPAC Meeting European Patient Advocacy Council F2F meeting where the topics for discussion were: 1. “Addressing inequalities in the patient voice across Europe”. 2. “Demonstrating the Impact of Patient Engagement”.
EMHA Participation at MTIS 2018: The past September 6th the European Migraine and Headache Alliance team flew all the way to London to assist to the 17th Biennial Migraine Trust International Symposium. It was an amazing and exciting event full of people interested in finding ways to give a brighter future to all migraine sufferers.
EMHA PARTICIPATION AT MTIS 2018 Read More »
Novartis marks a new era for migraine patients with the EU approval of Aimovig®, a first-of-its- kind treatment specifically designed for migraine prevention Jul 30, 2018 New Aimovig Medication Approved Novartis announced today that the European Commission (EC) approved Aimovig® (erenumab) for the prevention of migraine in adults experiencing four or more migraine days per month.
New Aimovig Medication Approved Read More »
Why is migraine still a big mystery to science Very common especially in women, these intense headaches are still a great medical mystery whose causes are not enlightened. Very common especially in women, these intense headaches are still a great medical mystery whose causes are not enlightened. Migraines are always related to a “simple headache”,
The science of migraine Read More »
11.3% of Spanish teenagers suffer from migraine headaches Migraine and teenagers The journal Cephalalgia – the scientific publication of the International Society of Headaches – has just published a study by members of the Headache Study Group of the Spanish Society of Neurology (SEN) of the Vall D’Hebron University Hospital, whose Objective was to evaluate
Migraine and teenagers Read More »
How to take care of your diet if you suffer migraine 30th MAY 2018 If we pay attention to what we eat, we can contribute to keeping headaches as far away from our lives as possible. If you have migraine, you probably know that maintaining a healthy lifestyle and respecting food and sleep schedules are
Don't miss out on any updates! Join our community and discover
the latest research, treatments, and events on migraine.
Subscribe now!
